June 2-6, 2023
This year's meeting will be in-person in Chicago and online.
The American Society of Clinical Oncology (ASCO) annual meeting offers premier scientific events for oncology professionals, patient advocates, industry representatives and major media outlets worldwide.
The 2023 ASCO annual meeting, held in Chicago, provides an opportunity to learn about the latest developments in cancer science from Fred Hutchinson Cancer Center and research institutions around the world. The program features more than 200 sessions complementing the meeting’s theme: Partnering with Patients - The Cornerstone of Cancer Care and Research.
Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance have merged to form Fred Hutchinson Cancer Center, a unified adult cancer research and care center that brings together SCCA and Fred Hutchinson Cancer Research Center into a single, independent, nonprofit organization that is also a clinically integrated part of UW Medicine and UW Medicine’s cancer program.
Oral Abstract | Poster Discussion Session | Poster Session | Publication Only
Oral Abstract: Risk of early mortality in patients with cancer experiencing adverse financial events.
Presenter: Hiba Khan
Poster Discussion Session: Dual PD1 and CTLA4 immune checkpoint blockade and hypofractionated radiation in patients with salivary gland cancers.
Presenter: Cristina Rodriguez
Poster Discussion Session: Five-year follow-up update of defined-composition CD19 CAR T-cell therapy for relapsed/refractory CLL.
Presenter: Emily Liang
Poster Discussion Session: The impact of adverse financial events on healthcare utilization and treatment costs at the end of life.
Presenter: Chipo Kwendakwema
Poster Session: Preclinical testing of FOLR1-CAR T cells against osteosarcoma (OS).
Presenter: Michelle Choe
Poster Session: Long-term efficacy and safety of pembrolizumab with R-CHOP as first-line therapy for DLBCL.
Presenter: Carrie Ho
Poster Session: Evaluation of cardiac failure and recovery in acute myelogenous leukemia.
Presenter: Matthew Wu
Poster Session: The somatic mutation profile of breast cancer in Uganda.
Presenter: Manoj Menon
Poster Session: PSMA expression and response to 177Lu-PSMA-617 (LuPSMA) in men with vs. without DNA damage repair (DDR) mutations.
Presenter: Ruben Raychaudhuri
Poster Session: Outcomes among adult recipients of CD19 CAR T-cell therapy for Burkitt lymphoma.
Presenter: Laura Samples
Poster Session: Impact of COVID-19 pandemic mitigation strategies on industry and NCI cancer treatment trials.
Presenter: Joseph Unger
Poster Session: Preclinical evaluation of targeting PRAME with TCR mimic CAR T cells in AML.
Presenter: Danielle Kirkey
Poster Session: Use of germline testing in patients with prostate, pancreatic, or ovarian cancer in Washington (WA) state.
Presenter: Veena Shankaran, Qin Sun
Poster Session: Phase I/II randomized clinical trial of in-clinic acupuncture prior to BCG in patients with high-risk non-muscle invasive bladder cancer.
Presenter: Sarah Psutka
Poster Session: Identification of factors to predict low risk febrile neutropenia admissions in patients with acute myeloid leukemia (AML) following intensive chemotherapy.
Presenter: Khushboo Pal
Poster Session: Outcomes with immune checkpoint inhibitors (ICI) in patients (pts) with MTAP alterations (alt) in advanced urothelial carcinoma (aUC).
Presenter: Rafee Talukder
Publication Only: Effect of change in ECOG performance status at diagnosis and relapse in patients with acute myeloid leukemia.
Presenter: Michelle Zhang
Publication Only: Attachment avoidance and anxiety impacting dyadic coping and communication in patients with metastatic sarcoma and their family caregivers.
Presenter: Courtney Daum
Publication Only: Comparison of conventional clinical models and a multigene assay to assess DCIS risk in a prospective single center study.
Presenter: Loise Wairiri
Publication Only: Osimertinib rechallenge in advanced EGFR non-small cell lung cancer patients.
Presenter: Natalie Uy